Literature DB >> 8272187

Investigations into the biochemical basis of neuromodulation by 2-phenylethylamine: effect on microtubule protein.

M E Knight1, J Harris.   

Abstract

In order to understand the role of 2-phenylethylamine (PE) on neuronal responses, membrane changes have been studied using ESR probes. We report that the anticipated change in lipid membrane fluidity generally implicated in signal transduction has not been observed when PE is added to synaptosomes. As cytoskeletal architecture of presynaptic terminals appears to be involved in synaptic transmission, we non-specifically labeled synaptosomal membrane proteins with the sulfhydryl spin probe N-(2,2,6,6-tetramethyl-piperidine-1-oxyl-4-yl) maleimide (4-MAL-TEMPO). The addition of 2-phenylethylamine was found to induce conformational changes, in decreasing the ratio of weakly to strongly immobilized spin label (W/S) to 65% of the control. Of the membrane proteins labeled, 70-90% of the 4-MAL-TEMPO is covalently incorporated into cytoskeletal proteins. In isolated synaptosomes, incorporated with spin-labeled tubulin, the addition of PE reduced the W/S ratio to 51.6% of that obtained for polymerized microtubules. In vitro, PE reduced tau R of polymerized microtubules by 37%. We propose that the PE interaction with tubulin changes microtubule dynamics which may lead to its neuromodulatory action. The state of microtubular assembly can modulate the responsiveness of second messengers in the cell to the effect of stimulatory agents. The nature and physiological significance of PE interaction with tubulin is currently under investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272187     DOI: 10.1007/bf00975039

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  45 in total

1.  An improved method for the preparation of synaptosomal fractions in high purity.

Authors:  F Hajós
Journal:  Brain Res       Date:  1975-08-15       Impact factor: 3.252

2.  Influences of colchicine, vinblastine and cytochalasin on the release of 5-hydroxytryptamine from rat brain synaptosomes.

Authors:  T Segawa; H Murakami; A Inouye; Y Tanaka
Journal:  J Neurochem       Date:  1978-01       Impact factor: 5.372

3.  Topology of a protein spin label in erythrocyte membranes.

Authors:  L W Fung; M J Simpson
Journal:  FEBS Lett       Date:  1979-12-01       Impact factor: 4.124

4.  Inhibitors of microtubule assembly enhance beta-adrenergic and prostaglandin E1-stimulated cyclic AMP accumulation in S49 lymphoma cells.

Authors:  M S Kennedy; P A Insel
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

5.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

6.  Intermembrane linkage mediated by tubulin.

Authors:  P Vassilev; M Kanazirska; H T Tien
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

7.  Assembly-disassembly purification and characterization of microtubule protein without glycerol.

Authors:  D B Murphy
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

8.  Complete amino acid sequence of beta-tubulin from porcine brain.

Authors:  E Krauhs; M Little; T Kempf; R Hofer-Warbinek; W Ade; H Ponstingl
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  Microtubule-dissociating drugs and A23187 reveal differences in the inhibition of synaptosomal transmitter release by botulinum neurotoxins types A and B.

Authors:  A C Ashton; J O Dolly
Journal:  J Neurochem       Date:  1991-03       Impact factor: 5.372

10.  Inhibition of release of dopamine- -hydroxylase and norepinephrine from sympathetic nerves by colchicine, vinblastine, or cytochalasin-B (hypogastric nerve stimulation-exocytosis-microtubules-microfilaments-guinea pig).

Authors:  N B Thoa; G F Wooten; J Axelrod; I J Kopin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.